Company Overview of Aeras
Aeras is a non-profit organization working through public-private partnerships to develop new vaccines against tuberculosis.
1405 Research Boulevard
Rockville, MD 20850
Founded in 1997
Key Executives for Aeras
Compensation as of Fiscal Year 2016.
Aeras Key Developments
Danilo Casimiro Joins Aeras as Chief Scientific Officer
Mar 1 16
Aeras announced that Danilo Casimiro, Ph.D., has joined the organization as Chief Scientific Officer (CSO) effective February 29. Dr. Casimiro joins Aeras from the Merck Research Laboratories, where he was Executive Director in the Department of Infectious Diseases and Vaccine Research. Dr. Casimiro will be filling the position recently vacated by Thomas G. Evans, M.D., who was formerly Aeras CEO and has been serving as Acting Chief Scientific Officer during the search for a permanent CSO.
Aeras Welcomes David Blumberg to its Board of Directors
Jul 20 15
David L. Blumberg recently joined Aeras's Board of Directors. He has more than 20 years of business and consulting experience across the life sciences continuum, including global, specialty, and generic pharmaceuticals, biotech, and medical devices and products. Mr. Blumberg recently retired from KPMG where he led their U.S. Pharmaceuticals and Life Sciences Advisory practice.
Aeras Announces Executive Changes
Jul 15 15
Aeras announced a new leadership structure for the nonprofit biotech organization with Jacqueline E. Shea, Ph.D., the current Chief Operating Officer (COO), assuming the role of Chief Executive Officer (CEO), effective August 12. Thomas G. Evans, M.D., will step down as CEO to become Acting Chief Scientific Officer (CSO). Ann M. Ginsberg, M.D., Ph.D., will continue as Chief Medical Officer.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries